Announced
Completed
Financials
Tags
Completed
shock wave therapy
Majority
Private
urology
Cross Border
Acquisition
China
Medical Equipment
Friendly
Single Bidder
Private Equity
Synopsis
Temasek-backed Advanced MedTech, an integrated urology company, completed the acquisition of a majority stake in WIKKON, the Chinese provider of urology and shock wave therapy devices. Financial terms were not disclosed. "We are now uniquely placed to aggressively grow in China’s sizeable market, which is best served by domestically produced devices. Advanced MedTech’s integrated urology platform is accelerated by WIKKON’s significant R&D, manufacturing, supply chain, and installed base of units. Our newly combined portfolio will allow us to serve urology customers seeking value oriented solutions right through to premium oriented customers globally," Abel Ang, Advanced MedTech CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.